The Procter & Gamble Company (BVL:PGUS)
Peru · Delayed Price · Currency is PEN · Price in USD | Market Cap | 1.14T -12.1% |
| Revenue (ttm) | 297.20B +3.3% |
| Net Income | 54.79B +0.5% |
| EPS | 22.61 +1.7% |
| Shares Out | n/a |
| PE Ratio | 20.89 |
| Forward PE | 19.99 |
| Dividend | 15.22 (3.01%) |
| Ex-Dividend Date | Jul 24, 2026 |
| Volume | n/a |
| Open | n/a |
| Previous Close | 149.13 |
| Day's Range | n/a |
| 52-Week Range | 140.28 - 171.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 29, 2026 |
About BVL:PGUS
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It als... [Read more]
Financial Performance
In fiscal year 2026, BVL:PGUS's revenue was $87.03 billion, an increase of 3.26% compared to the previous year's $84.28 billion. Earnings were $16.05 billion, an increase of 2.31%.
Financial numbers in USD Financial StatementsNews
Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US
A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and retailers such as CVS of selling billions of dollars o...
Procter & Gamble price target lowered to $162 from $163 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Procter & Gamble to $162 from $163 and keeps a Buy rating on the shares.
Procter & Gamble price target lowered to $160 from $166 at BofA
BofA lowered the firm’s price target on Procter & Gamble to $160 from $166 and keeps a Buy rating on the shares. The firm raised its FY27 and FY28 adjusted…
Procter & Gamble price target lowered to $170 from $181 at Citi
Citi lowered the firm’s price target on Procter & Gamble to $170 from $181 and keeps a Buy rating on the shares. The company reported “soft” fiscal Q4 results but…
HSBC downgrades Procter & Gamble to Hold after ‘weak’ Q4
HSBC analyst Diego Serrano downgraded Procter & Gamble to Hold from Buy with a price target of $149, down from $182. The company reported “weak” fiscal Q4 results and its…
Procter & Gamble downgraded to Hold from Buy at HSBC
HSBC downgraded Procter & Gamble to Hold from Buy with a $142 price target
Procter & Gamble Says Gas Prices Limiting Consumer Spending
Procter & Gamble says economic pressures have consumers focused on smaller pack sizes and promotions. The consumer packaged goods company released earnings Wednesday (July 29) showing sales up 3% for ...
Procter & Gamble's Stock Drops After Sales Miss Wall Street's Projections
Procter & Gamble's stock is taking a hit Wednesday after sales fell short of Wall Street estimates.
Procter & Gamble earnings: why CFO downplayed organic sales miss
Procter & Gamble (PG) shares opened in the red this morning as investors reacted to the Q4 sales miss and guidance that signalled potential cost headwinds. The consumer goods specialist posted $1.43 a...
Procter & Gamble sees Q1 EPS down 5% or more
Says met core objectives despite unexpected headwinds. Says managed through a very volatile environment. Says saw improvement in market share in the second half, despite some softening in underlying m...
Procter & Gamble (PG) Stock Slips on Mixed Earnings Results
Procter & Gamble stock was down after it reported earnings and a weak EPS guidance.
The Procter & Gamble Company Earnings Call Transcript: Q4 2026
Fiscal 2026 met guidance with broad-based growth, stable global share, and strong cash returns despite margin pressure and cost headwinds. Fiscal 2027 outlook calls for 1%-3% organic sales growth and continued investment in innovation, productivity, and digital transformation.
The Procter & Gamble Company Earnings release: Q4 2026
The Procter & Gamble Company released its Q4 2026 earnings on July 29, 2026, summarizing the period's financial results.
The Procter & Gamble Company Slides: Q4 2026
The Procter & Gamble Company has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on July 29, 2026.
P&G CFO Andre Schulten on Q4 results: Highest productivity number delivered in about a decade
Procter & Gamble CFO Andre Schulten joins 'Squawk Box' to discuss the company's quarterly earnings results, guidance for the new fiscal year, headwinds facing the company, state of the consumer, and m...
Procter & Gamble Profit Falls; Gives Soft Fiscal-Year Outlook
Fourth-quarter profit fell to $3.04 billion, driven by higher selling, general and administrative costs, which more than offset a slight uptick in sales.
Procter & Gamble appoints Shailesh Jejurikar as chairman of the board
The Procter & Gamble Company announced that Shailesh Jejurikar has been appointed Chairman of the Board, effective August 1, 2026. Jejurikar assumes the position in addition to his role as…
Procter & Gamble Earnings Beat Estimates. Why the Stock Is Still Falling.
Procter & Gamble reports better-than-expected quarterly profit but misses on sales.
Procter & Gamble revenue misses estimates as volume stays unchanged
Procter & Gamble reported quarterly earnings per share that topped Wall Street's estimates, but its revenue fell short of expectations. P&G also announced that CEO Shailesh Jejurikar will become chair...
Procter & Gamble reports Q4 core EPS $1.43, consensus $1.41
Reports Q4 revenue $$21.2B, consensus $21.38B. “Fiscal 2026 was a year of foundation building while continuing to grow sales and profit and return high levels of cash to shareowners despite…
Procter & Gamble provides update on portfolio, productivity plan
In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and invest in growth. The Company expects to…
Procter & Gamble sees FY27 core EPS $6.89-$7.11, consensus $7.05
P&G expects fiscal year 2027 all-in sales growth in the range of one to three percent versus the prior year. The Company also expects organic sales growth in the range…
P&G forecasts muted 2027 as tighter consumer spending hurt demand
Procter & Gamble forecast slower revenue and profit growth in fiscal 2027 on Wednesday after quarterly sales missed estimates due to uneven demand in categories such as grooming and oral care from a...
Shailesh Jejurikar Appointed Chairman of P&G Board of Directors
CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) today announced that Shailesh Jejurikar has been appointed Chairman of the Board, effective August 1, 2026. Jejurikar assumes the po...
How P&G Is Trying to Sell Tide and Bounty to Inflation-Squeezed Consumers
The consumer-products giants is working “harder than we've had to in a long time” to win over shoppers, its CFO says.